40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
7.91B
Better than VET's estimated revenue of 1.74B.
1.58B
Better than VET's estimated ebitda of 790.69M.
5.21
Better than VET's estimated eps of 2.93.
1.38B
Better than VET's estimated net income of 479.25M.
-23.87M
Worse than VET's estimated ebit of 220.62M.
1.37B
Worse than VET's estimated sg&a expense of 139.62M.
Analyze DCF forecasts for the company and compare them with competitors.
17.93B
Better than VET's revenue of 4.49B.
14.39%
Worse than VET's revenue growth rate of 24.76%.
3.71B
Better than VET's ebitda of 1.94B.
20.72%
Worse than VET's ebitda margin of 43.10%.
272.50M
Worse than VET's ebit of 503.96M.
1.52%
Worse than VET's ebit margin of 11.22%.
3.44B
Worse than VET's depreciation of 1.43B.
105.55M
Worse than VET's total cash of 125.61M.
0.59%
Worse than VET's cash as percentage of revenue of 2.80%.
2.38B
Worse than VET's receivables of 592.67M.
13.27%
Worse than VET's receivables as percentage of revenue of 13.19%.
17.28M
Better than VET's inventories of 63.56M.
0.10%
Better than VET's inventories as percentage of revenue of 1.41%.
809.04M
Worse than VET's accounts payable of 708.44M.
4.51%
Better than VET's payables as percentage of revenue of 15.77%.
-4.00B
Better than VET's capital expenditure of -1.07B.
-22.33%
Worse than VET's capex as percentage of revenue of -23.72%.
8.16%
Better than VET's weighted average cost of capital (wacc) of 9.46%.
9.50%
Better than VET's cost of equity of 11.33%.
6.55%
Better than VET's cost of debt of 8.31%.
1.15
Better than VET's beta of 1.54.
267.40M
Worse than VET's diluted shares outstanding of 158.07M.
6.29B
Worse than VET's total debt of 729.91M.
9.59B
Better than VET's total equity of 1.01B.
15.88B
Better than VET's total capital of 1.74B.
39.62%
Better than VET's debt weighting of 41.95%.
60.38%
Better than VET's equity weighting of 58.05%.
254.15M
Worse than VET's ebiat of 416.62M.
-507.05M
Worse than VET's unlevered free cash flow of 793.87M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-6.65B
Worse than VET's terminal value of 10.85B.
-6.15B
Worse than VET's enterprise value of 8.84B.
6.25B
Worse than VET's net debt of 635.50M.
-12.40B
Worse than VET's equity value of 8.21B.
-46.36
Worse than VET's equity value per share of 51.93.
